- Parents or guardians should be informed by the healthcare provider of the potential benefits and risks of immunization with KINRIX (diptheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine) .
- The healthcare provider should inform the parents or guardians about the potential for adverse reactions that have been temporally associated with administration of KINRIX (diptheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine) or other vaccines containing similar components.
- The parent or guardian accompanying the recipient should be instructed to report any adverse events to their healthcare provider where the vaccine was administered.
- The parent or guardian should be given the Vaccine Information Statements, which are required by the National Childhood Vaccine Injury Act of 1986 to be given prior to immunization. These materials are available free of charge at the Centers for Disease Control and Prevention (CDC) website (www.cdc.gov/nip).
KINRIX (diptheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine) is a trademark and INFANRIX, PEDIARIX, and TIP-LOK are registered trademarks of GlaxoSmithKline. IPOL is a registered trademark of Sanofi Pasteur Limited.
Last reviewed on RxList: 7/23/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Kinrix Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.